Boston Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-13,154
Closed -$861K 617
2019
Q2
$861K Buy
13,154
+6,455
+96% +$372K 0.05% 392
2019
Q1
$395K Buy
+6,699
New +$400K 0.02% 506
2018
Q4
Sell
-32,363
Closed -$1.94M 649
2018
Q3
$1.94M Buy
+32,363
New +$1.77M 0.08% 284
2018
Q2
Sell
-17,655
Closed -$616K 665
2018
Q1
$616K Sell
17,655
-5,870
-25% -$214K 0.02% 459
2017
Q4
$853K Buy
+23,525
New +$825K 0.02% 401

Other funds holding MEDP

Boston Advisors's MEDP Position: Q3 2019 in Review

Boston Advisors sold out of Medpace (MEDP) in Q3 2019, closing a stake of 13,154 shares — an estimated $861K sold.

Boston Advisors first reported a position in MEDP in Q4 2017 and held it in 5 quarters. The position peaked at $1.94M in Q3 2018. 268 funds tracked by Wall St. Rank hold MEDP as of Q3 2019.

  • Boston Advisors reported no remaining Medpace position as of Q3 2019 after selling out during the quarter.
  • Boston Advisors sold 13,154 Medpace shares in Q3 2019, an estimated $861K.
  • Boston Advisors first reported a position in Medpace in Q4 2017 and held it in 5 quarters.
  • Boston Advisors's Medpace position peaked at $1.94M in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Medpace as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.